Genetic variability in serotonin receptor and transporter genes may influence risk for tardive dyskinesia in chronic schizophrenia.
Ching-Jow
CJ
Hsieh
Yen-Ching
YC
Chen
Mei-Shu
MS
Lai
Chen-Jee
CJ
Hong
Kuo-Liong
KL
Chien
D014150:Antipsychotic Agents / Q000009:adverse effects; D003545:Cysteine / Q000235:genetics; D004198:Disease Susceptibility; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000209:etiology / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D044406:Receptors, Serotonin, 5-HT3 / Q000235:genetics*; D012307:Risk Factors; D012559:Schizophrenia / Q000188:drug therapy; D050486:Serotonin Plasma Membrane Transport Proteins / Q000235:genetics*; D013624:Taiwan; D013912:Threonine / Q000235:genetics
D014150:Antipsychotic Agents; C509409:HTR3A protein, human; D044406:Receptors, Serotonin, 5-HT3; D050486:Serotonin Plasma Membrane Transport Proteins; D013912:Threonine; D003545:Cysteine